Specificity of binding with matrix metalloproteinases (Q38014070)

27 August 2017

title

Specificity of binding with matrix metalloproteinases (English)

1 reference

27 August 2017

Satya P Gupta

1

1 reference

27 August 2017

Vaishali M Patil

series ordinal

2

1 reference

27 August 2017

language of work or name

1 reference

1 January 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

103

1 reference

27 August 2017

page(s)

35-56

1 reference

Structural bases for substrate and inhibitor recognition by matrix metalloproteinases

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Snapshots of the Reaction Mechanism of Matrix Metalloproteinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Insights into MMP-TIMP interactions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Matrix metalloproteinase inhibitors in arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Tissue inhibitors of metalloproteinases: evolution, structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structures of matrilysin-inhibitor complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structural basis for the highly selective inhibition of MMP-13.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Matrix metalloproteinases: useful and deleterious

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structural aspects of the metzincin clan of metalloendopeptidases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

The NMR structure of the inhibited catalytic domain of human stromelysin–1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Collagenolytic activity in amphibian tissues: a tissue culture assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Quantitative structure-activity relationship studies on zinc-containing metalloproteinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Families of zinc metalloproteases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Selective matrix metalloproteinase inhibitors for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Protease degradomics: a new challenge for proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Proteolysis and cell migration: creating a path?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure and function of matrix metalloproteinases and TIMPs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Role of proteolytic enzymes in biological regulation (a review)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Towards third generation matrix metalloproteinase inhibitors for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Heterocycle-based MMP inhibitors with P2' substituents

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Potent, selective pyrimidinetrione-based inhibitors of MMP-13

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

On the size of the active site in proteases. I. Papain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

The design, structure, and therapeutic application of matrix metalloproteinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Key feature of the catalytic cycle of TNF-alpha converting enzyme involves communication between distal protein sites and the enzyme catalytic core

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structure of human neutrophil collagenase reveals large S1′ specificity pocket

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

How matrix metalloproteinases regulate cell behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Matrix metalloproteinases: fold and function of their catalytic domains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Structural Differences of Matrix Metalloproteinases with Potential Implications for Inhibitor Selectivity Examined by the GRID/CPCA Approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog a

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

A novel series of highly selective inhibitors of MMP-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Design and therapeutic application of matrix metalloproteinase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Recent developments in the design of angiotensin-converting enzyme inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

Matrix metalloproteinases and diseases of the CNS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0364-9_2

10.1007/978-3-0348-0364-9_2

31 March 2020

Identifiers

DOI

1 reference

27 August 2017

1 reference